An update on the pharmacological management of endometriosis.
about
Molecular aspects of development and regulation of endometriosisInnovations in classical hormonal targets for endometriosis.Impact of surgical excision of lesions on pain in a rat model of endometriosis.Oxidation-sensitive nociception involved in endometriosis-associated pain.Lipoxin A₄ prevents the progression of de novo and established endometriosis in a mouse model by attenuating prostaglandin E₂ production and estrogen signalingSoluble ligands for the NKG2D receptor are released during endometriosis and correlate with disease severity.Endometriosis: alternative methods of medical treatment.Nationwide trends in the performance of inpatient hysterectomy in the United States.Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study.A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.Triptorelin for the treatment of endometriosis.Dienogest in the treatment of endometriosis.An update on the pharmacological management of adenomyosis.Pathogenetic Mechanisms of Deep Infiltrating Endometriosis.Experimental treatments of endometriosis.MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis?Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics.Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience.Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.Surgery versus pharmacological treatment for endometriosis.Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.Contraception and endometriosis: challenges, efficacy, and therapeutic importance.Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development.Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.The effects of different doses of melatonin treatment on endometrial implants in an oophorectomized rat endometriosis model.Endometriosis after menopause: physiopathology and management of an uncommon condition.Endometriosis of the lumbosacral plexus: report of a case with foot drop and chronic pelvic pain.Shaofu Zhuyu Decoction Regresses Endometriotic Lesions in a Rat Model.Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemiaNew insights on the pathogenesis of endometriosis and novel non-surgical therapies
P2860
Q26865356-51F7DBEE-8413-411E-8D12-33D5DBE2F335Q34504377-404E30CD-88D4-42A4-B67A-62C5A3C389E9Q34506185-BCDD40C5-DB6F-4743-8174-B9550470E335Q35085111-8FD11FE5-4EFD-4215-BF2E-C0D082D12C67Q35107985-96DA4576-2880-4B4C-AFDE-D2999C98BB11Q35181683-A279C378-92A4-47FA-8022-F5D06DA7C881Q35668144-6BB5F2E8-6C17-48A1-A0C5-36EBCD9C89B9Q37552613-3BF9E2FE-2218-435E-8A0F-C0E52414AB50Q37616242-A3A184A0-013D-4AB3-9712-9F94AB10B335Q38192713-2FB972ED-23CF-4BDD-8E29-2333AAA2CF80Q38212096-100A6AEE-F3EF-4469-A818-EE1E16364F44Q38234673-751886EB-2E92-46D1-9909-8977ACB35DABQ38246723-3D92DCA6-2B55-4F3E-BD90-D5F8BC9BCA97Q38546195-CD2A4CB8-C21C-45E1-8B2C-9B7C0E4322E0Q38575273-63DE7114-AC89-41F3-A890-A29C1354BADFQ38590189-1513CADA-07DB-4648-9401-8C83E04D34A0Q38689176-DDDFD7C8-9E02-409D-9C75-1C379D82B4A8Q38700968-A918085C-C597-4B7D-804B-294D6CAFA931Q39183896-5005BDE3-5F3A-4DA5-904D-4FDA72B32805Q39237412-ECADB496-CC05-43BA-BD5E-11678BD83826Q40743672-E4C3E2BE-8564-419A-85A3-A2E1628B6618Q47549796-2508F801-ABFA-4793-8475-9812ED62EAD6Q48059956-A6AFA149-AA92-466A-BA35-A45BB35D24E8Q49884536-D4307563-F61D-4F6E-A75D-A9E99312BB08Q49946675-820C9775-F9A7-4913-B8B5-FF7964253A58Q51113145-C9FBE105-1F4C-4305-8E49-8B6D2588CFBDQ52892204-9EA175AD-8A00-404B-B67F-3E6FBD5F6713Q53610641-242CE52D-25F0-4AB0-A996-05E788BA41D7Q55077369-D26DE925-6EE8-4706-B6D5-4AB544F5E2A1Q56973086-56E9D0BB-0A1A-4821-83A7-481E343A45B3Q58799203-8DD9C333-9D31-4326-9FE6-4558F8BA195B
P2860
An update on the pharmacological management of endometriosis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
An update on the pharmacological management of endometriosis.
@ast
An update on the pharmacological management of endometriosis.
@en
An update on the pharmacological management of endometriosis.
@nl
type
label
An update on the pharmacological management of endometriosis.
@ast
An update on the pharmacological management of endometriosis.
@en
An update on the pharmacological management of endometriosis.
@nl
prefLabel
An update on the pharmacological management of endometriosis.
@ast
An update on the pharmacological management of endometriosis.
@en
An update on the pharmacological management of endometriosis.
@nl
P2093
P2860
P1476
An update on the pharmacological management of endometriosis.
@en
P2093
Bruno Borghese
Dominique de Ziegler
Frédéric Batteux
Isabelle Streuli
Louis Marcellin
Pietro Santulli
P2860
P304
P356
10.1517/14656566.2013.767334
P407
P577
2013-01-29T00:00:00Z